1 Min Read
May 15 (Reuters) - Amicus Therapeutics Inc
* Amicus therapeutics announces positive functional data from initial patients in pompe phase 1/2 study Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.